• JGC will achieve the continuous manufacturing of bulk drugs by introducing the technologies of CONTINUUS Pharmaceuticals (hereinafter, CONTINUUS) of the U.S. This will also enable the continuous and seamless manufacturing of pharmaceutical preparations.

• A pilot plant using this technology is currently being operated in Boston of the U.S.

  • Click here for the video of CONTINUUS' pilot plant
• JGC will act as a mediator between CONTINUUS and customers, and construct the pilot plant and commercial facilities in Japan.

JGC was one of the first companies to carry out technological investigations into the continuous manufacturing of pharmaceutical preparations, and the company has shared technologies with not only domestic companies, but also equipment manufacturers in Europe and the U.S. Moreover, by applying JGC's technologies for controlling continuous manufacturing in the oil and gas sector to life sciences, the company has been striving to achieve the continuous manufacturing of pharmaceuticals, lowering of equipment costs, handling of wide-variety-small-lot production, and the saving of space and manpower.
Furthermore, taking advantage of the characteristics of the compact continuous manufacturing equipment for solid preparations to modularize factories will realize the shortening of construction times, and allow the company to offer proposals for modular factories, which are easier to transfer.

Continuous Manufacturing of Solid Preparations

• Please click here for inquiries about Continuous Manufacturing Technology.